We are live on ! Find out more
IRD

Opus Genetics
IRD

35 hedge funds and large institutions have $6.57M invested in Opus Genetics in 2014 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 8

0% more funds holding

Funds holding: 35 → 35 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

49% less capital invested

Capital invested by funds: $12.9M → $6.57M (-$6.35M)

Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
11
Reduced
8
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$829K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$196K
3
CCM
Condor Capital Management
New Jersey
+$109K
4
Deutsche Bank
Deutsche Bank
Germany
+$96.8K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$82.3K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.29M
2
SFM
Sphera Funds Management
Israel
-$2.17M
3
PAM
Panagora Asset Management
Massachusetts
-$354K
4
BG
BlackRock Group
United Kingdom
-$340K
5
U
UBS
Switzerland
-$315K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.11M +$18.6K +41 +0.6%
Morgan Stanley
2
Morgan Stanley
New York
$1.07M +$829K +1,824 +243%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$621K +$196K +432 +41%
Northern Trust
4
Northern Trust
Illinois
$205K +$34.1K +75 +18%
AQR Capital Management
5
AQR Capital Management
Connecticut
$186K -$158K -347 -44%
BCM
6
Bridgeway Capital Management
Texas
$157K – – –
Wells Fargo
7
Wells Fargo
California
$133K +$6.82K +15 +5%
NFC
8
Northeast Financial Consultants
Connecticut
$130K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$111K +$82.3K +181 +210%
CCM
10
Condor Capital Management
New Jersey
$100K +$109K +240 New
Commonwealth Equity Services
11
Commonwealth Equity Services
Massachusetts
$94K +$14.5K +32 +17%
Deutsche Bank
12
Deutsche Bank
Germany
$88K +$96.8K +213 New
BMC
13
Benin Management Corp
Connecticut
$72K – – –
Citadel Advisors
14
Citadel Advisors
Florida
$65K +$70.5K +155 New
GC
15
Guggenheim Capital
Illinois
$58K -$6.36K -14 -9%
Bank of America
16
Bank of America
North Carolina
$57K – – –
Goldman Sachs
17
Goldman Sachs
New York
$53K -$27.7K -61 -32%
State Street
18
State Street
Massachusetts
$32K – – –
BA
19
BlackRock Advisors
Delaware
$31K – – –
OC
20
Oppenheimer & Co
New York
$23K -$50.5K -111 -66%
MC
21
Moors & Cabot
Massachusetts
$22K +$13.2K +29 +126%
VKH
22
Virtu KCG Holdings
New York
$19K -$269K -592 -93%
ASN
23
Advisory Services Network
Georgia
$19K +$20.9K +46 New
U
24
UBS
Switzerland
$17K -$315K -693 -95%
Two Sigma Investments
25
Two Sigma Investments
New York
$16K +$17.7K +39 New
1
2

IRD Hedge Fund Activity: Q2 2014 in Review

35 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2014, worth a combined $6.57M — down 49% from $12.9M a quarter earlier.

Fund positioning in IRD was balanced in Q2 2014: 9 funds opened new positions, 9 closed out, 11 added to existing stakes and 8 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $829K. The largest seller was Millennium Management, exiting entirely with an estimated $2.29M sold.

  • 35 institutional investors held Opus Genetics (IRD) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $6.57M of Opus Genetics stock for Q2 2014, down 49% quarter-over-quarter.
  • 9 funds opened new Opus Genetics positions in Q2 2014 and 9 closed out, a net change of 0 holders.
  • The largest Opus Genetics buyer in Q2 2014 was Morgan Stanley, an estimated $829K added.
  • The largest Opus Genetics seller in Q2 2014 was Millennium Management, an estimated $2.29M sold.

Based on aggregated 13F filings for Q2 2014.